AN2 Therapeutics, Inc. (ANTX)
About AN2 Therapeutics, Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$35.2M
- Total assets
- $62.0M
- Market cap
- $137.6M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $56.8M
- Operating income
- -$56.8M
- Income tax
- $0
- Net income
- -$51.3M
- EPS (basic)
- $-1.72
- EPS (diluted)
- $-1.72
Balance sheet
- Total assets
- $92.1M
- Current assets
- $86.3M
- Total liabilities
- $10.2M
- Current liabilities
- $10.2M
- Shareholders’ equity
- $81.8M
Cash flow
- Operating cash flow
- -$49.3M
- Investing cash flow
- $54.6M
- Financing cash flow
- $372.0K
- Net cash flow
- $5.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $137.6M
- EPS (diluted)
- $-1.72
- Dividend yield
- 53.35%
- Shares outstanding
- 28.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 25, 2022
AN2 Therapeutics, Inc. (ANTX) Stock Price
- Reported a net loss of $35.2M.
- Trading 10% below its 52-week high.
- Pays a dividend yielding about 53.35% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review AN2 Therapeutics, Inc..
Write a review
News about AN2 Therapeutics, Inc.
News & sentiment via Polygon.io
AN2 Therapeutics, Inc.: frequently asked questions
Is AN2 Therapeutics, Inc. an American company?
AN2 Therapeutics, Inc. is a US-based company headquartered in Menlo Park, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is AN2 Therapeutics, Inc. headquartered?
AN2 Therapeutics, Inc. is headquartered in Menlo Park, California, United States.
Is AN2 Therapeutics, Inc. publicly traded?
Yes — AN2 Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol ANTX on the NASDAQ.
What does AN2 Therapeutics, Inc. do?
AN2 Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
